SCHEMBL349518

SCHEMBL349518

CC[N+](CC)(CC)C(C)C

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
KCNA1 Q09470 1/20 0.33
KDM4E B2RXH2 1/20 0.31
PMP22 Q01453 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31683057 0.96 KDM4E (0.38) TSHRNFKB1KCNA1KDM4EPMP22
Bromide SCHEMBL31683090 0.96 TSHR (0.31) TSHRNFKB1KCNA1
Fluoride Ion SCHEMBL31683151 0.96 TSHR (0.31) TSHRNFKB1KCNA1
Water SCHEMBL31683099 0.96 TSHR (0.31) TSHRNFKB1KCNA1
Iodide SCHEMBL31683153 0.96 TSHR (0.31) TSHRNFKB1KCNA1
SCHEMBL19409348 0.87
SCHEMBL28698463 0.82 ALPG (0.32)
SCHEMBL1833510 0.79 SLC22A1 (0.44) TSHRNFKB1KCNA1KDM4EPMP22
SCHEMBL19420613 0.79
SCHEMBL1833579 0.79 SLC22A1 (0.37) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108148394-B Storage-stable one-component polyurethane prepregs from polyurethane compositions and moldings produced therefrom 赢创运营有限公司 2021-12-28 CN claimed
US-20250340517-A1 HIGH-DIELECTRIC CONSTANT ZWITTERIONIC LIQUIDS PENN STATE RES FOUND (US) 2025-11-06 US disclosed
EP-3578541-B1 COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-05-28 EP disclosed
CN-108863966-B Process for preparing trimers and/or oligomers of diisocyanates 赢创运营有限公司 2023-12-08 CN disclosed
WO-2023225050-A1 HIGH-DIELECTRIC CONSTANT ZWITTERIONIC LIQUIDS THE PENN STATE RESEARCH FOUNDATION (US) 2023-11-23 WO disclosed
EP-3232455-B1 NONAQUEOUS ELECTROLYTE SOLUTION FOR ELECTRIC DOUBLE LAYER CAPACITORS OTSUKA CHEMICAL CO LTD (JP) 2023-10-25 EP disclosed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
EP-3215172-B1 MODIFICATIONS AND USES OF CONOTOXIN PEPTIDES KINETA CHRONIC PAIN LLC (US) 2023-04-26 EP disclosed
US-11618772-B2 Modifications and uses of conotoxin peptides KINETA CHRONIC PAIN, LLC 2023-04-04 US disclosed
EP-0956292-A1 CONANTOKINS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1999-11-17 EP disclosed
US-5719280-A REACTING AMINE SUBSTITUTED BENZOCYCLOALKANE WITH DIALKYLOXYACETALDEHYDE IN PRESENCE OF REDUCING AGENT OR CATALYTIC HYDROGENATION, TREATING WITH THIOCYANIC ACID SYNTEX (U.S.A.) INC. (US) 1998-02-17 US disclosed
WO-1998003189-A1 USE OF CONANTOKINS COGNETIX, INC. (US) 1998-01-29 WO disclosed
WO-1998003541-A1 CONANTOKINS UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) 1998-01-29 WO disclosed
EP-0757677-A1 BENZOCYCLOALKYLAZOLETHIONE DERIVATIVES SYNTEX (U.S.A.) INC. (US) 1997-02-12 EP disclosed
US-5538988-A CARDIOVASCULAR DISORDERS AND DOPAMINE HYDROLASE ENZYME INHIBITORS SYNTEX (U.S.A.) INC. 1996-07-23 US disclosed
WO-1995029165-A2 BENZOCYCLOALKYLAZ0LETHIONE DERIVATIVES AS DOPAMIN BETA-HYDROXYLASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1995-11-02 WO disclosed
US-5344837-A Platelet aggregation inhibitors G.D. SEARLE & CO. (US) 1994-09-06 US disclosed
WO-1994001396-A1 PHENYL AMIDINE UREA DERIVATIVES AS PLATELET AGGREGATION INHIBITORS G.D. SEARLE & CO. (US) 1994-01-20 WO disclosed
US-5272162-A Platelet aggregation inhibitors G. D. SEARLE & CO. (US) 1993-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC TSHR 3824/4885NFKB1 2929/4885KCNA1 4451/4885
US-11618772-B2 Modifications and uses of conotoxin peptides CHRNA9, CHRNA10, CHRNA7 TSHR 1327/4885NFKB1 3040/4885KCNA1 204/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC TSHR 3824/4885NFKB1 2929/4885KCNA1 4451/4885
US-20250340517-A1 HIGH-DIELECTRIC CONSTANT ZWITTERIONIC LIQUIDS KCNH3, KCNN2, KCNN1 TSHR 4710/4885NFKB1 3836/4885KCNA1 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.